TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23759131

Group type: EXPERIMENTAL
Intervention: Antenatal stability ball exercise programme (12 weeks, 3 sessions per week, 25-30 minutes each session)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 89
Study: 22950512

Group type: EXPERIMENTAL
Intervention: P. falciparum infection
Number of subjects: 2400

Group type: EXPERIMENTAL
Intervention: Anaemia
Number of subjects: 2400

Group type: EXPERIMENTAL
Intervention: Risk factors for P. falciparum infection
Number of subjects: 2400

Group type: EXPERIMENTAL
Intervention: Risk factors for anaemia
Number of subjects: 2400

Group type: EXPERIMENTAL
Intervention: Cognitive and educational performance
Number of subjects: 2400
Study: 19430064

Group type: EXPERIMENTAL
Intervention: Silicon gel sheeting applied to nares (Group 2, n=92)
Number of subjects: 179

Group type: COMPARATOR
Intervention: No silicon gel applied to nares (Group 1, n=87)
Number of subjects: 179
Study: 18555936

Group type: EXPERIMENTAL
Intervention: Zidovudine 100 mg (test formulation)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Zidovudine 100 mg (reference formulation)
Number of subjects: 24
Study: 16055570

Group type: EXPERIMENTAL
Intervention: 400 microg of vaginal misoprostol, given 3-4 hours preoperatively
Number of subjects: 84

Group type: COMPARATOR
Intervention: Overnight laminaria
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 84
Study: 12120699

Group type: EXPERIMENTAL
Intervention: MS patients
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 51
Study: 10321112

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 10985

Group type: COMPARATOR
Intervention: Conventional treatment (diuretics or beta-blockers)
Number of subjects: 10985
Study: 8727240

Group type: EXPERIMENTAL
Intervention: Antidepressant medication
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 1748257

Group type: EXPERIMENTAL
Intervention: Insulin therapy
Number of subjects: 471

Group type: COMPARATOR
Intervention: Diet therapy
Number of subjects: 471

Group type: COMPARATOR
Intervention: Diet therapy in obese subjects
Number of subjects: 471
Study: 7201759

Group type: EXPERIMENTAL
Intervention: Administration of undiluted erythrocytes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dilution of packed erythrocytes with at least 100 ml of normal saline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transfusion flow rates for packed red blood cells
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: External bag pressure and transfusion apparatus
Number of subjects: 0
Study: 31200671

Group type: EXPERIMENTAL
Intervention: DIALOG+ intervention in Uganda
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DIALOG+ intervention in Colombia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DIALOG+ intervention in Bosnia-Herzegovina
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Volunteer Support intervention in Uganda
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Volunteer Support intervention in Colombia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Volunteer Support intervention in Bosnia-Herzegovina
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Family Involvement intervention in Uganda
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Family Involvement intervention in Colombia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Family Involvement intervention in Bosnia-Herzegovina
Number of subjects: 0
Study: 27387376

Group type: EXPERIMENTAL
Intervention: Anagram generation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imagery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reading (control)
Number of subjects: 0
Study: 26170351

Group type: COMPARATOR
Intervention: Pregabalin 0 mg
Number of subjects: 120
Study: 24357936

Group type: EXPERIMENTAL
Intervention: GSK2190915 10 mg
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: GSK2190915 50 mg
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 20562122

Group type: EXPERIMENTAL
Intervention: Mobile telephone-based interactive asthma self-care system
Number of subjects: 89
Study: 19620846

Group type: EXPERIMENTAL
Intervention: Modafinil 100-mg capsule BID
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Modafinil and Placebo
Number of subjects: 19
Study: 16505497

Group type: EXPERIMENTAL
Intervention: Pioglitazone 45 mg
Number of subjects: 19

Group type: COMPARATOR
Intervention: Glipizide 10 mg
Number of subjects: 19
Study: 15312219

Group type: EXPERIMENTAL
Intervention: Consensus definition for ARF developed
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recommendations for future investigations
Number of subjects: 0
Study: 11331721

Group type: EXPERIMENTAL
Intervention: Porcine secretin
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 9118764

Group type: EXPERIMENTAL
Intervention: Recommendation for special shoes
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Shoe length
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Shoe width
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Bought shoes in the past 6 months
Number of subjects: 352
Study: 8320055

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (1 g/day for 28 days)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Alpha-tocopherol (1 g/day for 28 days)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Alpha-tocopherol and ascorbic acid (1 g/day for 28 days each)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 3090049

Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation
Number of subjects: 42

Group type: COMPARATOR
Intervention: Manipulative reduction and plaster
Number of subjects: 42
Study: 29203268

Group type: EXPERIMENTAL
Intervention: Blue light flexible cystoscopy
Number of subjects: 304

Group type: COMPARATOR
Intervention: White light flexible cystoscopy
Number of subjects: 304
Study: 27824768

Group type: EXPERIMENTAL
Intervention: Excessive gestational weight gain
Number of subjects: 841
Study: 25663279

Group type: EXPERIMENTAL
Intervention: Autologous blood pleurodesis (ABP)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Tetracycline pleurodesis
Number of subjects: 48
Study: 23480441

Group type: EXPERIMENTAL
Intervention: Modified Magill forceps
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard Magill forceps
Number of subjects: 150
Study: 21181560

Group type: EXPERIMENTAL
Intervention: Video-intervention (8-minute video depicting clinician expert and patients discussing challenges in seeking treatment for sickle cell pain)
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Video-intervention
Number of subjects: 276
Study: 19720914

Group type: EXPERIMENTAL
Intervention: Extra boost dose of 16 Gy
Number of subjects: 1616

Group type: COMPARATOR
Intervention: Margin status (negative, close, positive)
Number of subjects: 1616

Group type: COMPARATOR
Intervention: Age younger than 50 years
Number of subjects: 1616

Group type: COMPARATOR
Intervention: High-grade invasive ductal carcinoma
Number of subjects: 1616
Study: 17315077

Group type: EXPERIMENTAL
Intervention: Bifidobacterium lactis HN019 (high dose: 5 x 10^9 CFU/day)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Bifidobacterium lactis HN019 (medium dose: 1.0 x 10^9 CFU/day)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Bifidobacterium lactis HN019 (low dose: 6.5 x 10^7 CFU/day)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (no probiotic supplement)
Number of subjects: 80
Study: 15285601

Group type: EXPERIMENTAL
Intervention: Prefactual reasoning
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Counterfactual reasoning
Number of subjects: 0
Study: 11690570

Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D supplements
Number of subjects: 145

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Calcium intake of at least 1000 mg per day
Number of subjects: 145

Group type: COMPARATOR
Intervention: Calcium intake of less than 1000 mg per day
Number of subjects: 145
Study: 9399717

Group type: EXPERIMENTAL
Intervention: Normal daily physical activities (Group 1, 54 patients)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Immobilization during recording (Group 2, 52 patients)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 106
Study: 8548234

Group type: EXPERIMENTAL
Intervention: Antioxidant concentration measured before and after exercise
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Microalbuminuria measured before and after exercise
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Correlation between antioxidant concentration and microalbuminuria
Number of subjects: 29

Group type: COMPARATOR
Intervention: Total antioxidant concentration at rest
Number of subjects: 29
Study: 2502004

Group type: EXPERIMENTAL
Intervention: Coadministration of 344 mumol of zinc
Number of subjects: 0

Group type: COMPARATOR
Intervention: 421 mumol of Fe alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 421 mumol of Zn
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1048 mumol of Zn
Number of subjects: 0
Study: 320112

Group type: EXPERIMENTAL
Intervention: Duogastrone (50 mg capsules, 200 mg daily for 12 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 31494973

Group type: EXPERIMENTAL
Intervention: Picosecond alexandrite laser treatment (3 sessions at 4-week intervals)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Picosecond alexandrite laser treatment (5 sessions at 4-week intervals)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Triple combination cream (TCC) daily for at least 8 weeks
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Picosecond alexandrite laser treatment (3 sessions)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Picosecond alexandrite laser treatment (5 sessions)
Number of subjects: 29
Study: 31277968

Group type: EXPERIMENTAL
Intervention: SC+ACT‐ED
Number of subjects: 53
Study: 28486907

Group type: EXPERIMENTAL
Intervention: Crocin (15 mg twice a day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (twice a day)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Crocin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 25367014

Group type: EXPERIMENTAL
Intervention: Virtual reality (VR) training scenario for social eating situations
Number of subjects: 37
Study: 26218762

Group type: EXPERIMENTAL
Intervention: HF10 therapy
Number of subjects: 198

Group type: COMPARATOR
Intervention: Traditional low-frequency SCS
Number of subjects: 198
Study: 23314000

Group type: EXPERIMENTAL
Intervention: Routine Family Therapy (RFT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 50
Study: 20439790

Group type: EXPERIMENTAL
Intervention: Foster care intervention
Number of subjects: 136

Group type: COMPARATOR
Intervention: Care as usual (institutional care)
Number of subjects: 136
Study: 19029421

Group type: COMPARATOR
Intervention: Standard therapy (androgen deprivation)
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Chemohormonal group (ketoconazole and doxorubicin alternating with vinblastine and estramustine)
Number of subjects: 286
Study: 16774150

Group type: EXPERIMENTAL
Intervention: Oral melatonin (0.3 mg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Oral melatonin (5.0 mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 12966323

Group type: EXPERIMENTAL
Intervention: Naltrexone 50 mg
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 10963173

Group type: EXPERIMENTAL
Intervention: Insole with a lateral wedge (group I)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conservative treatment without an insole (group II)
Number of subjects: 30
Study: 9205160

Group type: EXPERIMENTAL
Intervention: alpha-ketoglutarate (28 g added to blood cardioplegia)
Number of subjects: 24
Study: 7959497

Group type: EXPERIMENTAL
Intervention: Chloral hydrate (1,000 mg daily for six days)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 2455180

Group type: EXPERIMENTAL
Intervention: Clonidine treatment (150 micrograms t.i.d. for 2 weeks)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Clonidine treatment (0.36 ± 0.07 mg daily for 1 month)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Propranolol treatment (160 mg daily for 1 month)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Clonidine withdrawal
Number of subjects: 24

Group type: COMPARATOR
Intervention: Propranolol withdrawal
Number of subjects: 24
Study: 31958274

Group type: EXPERIMENTAL
Intervention: Fatigue numeric rating scale (NRS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fatigue NRS
Number of subjects: 0
Study: 29804059

Group type: EXPERIMENTAL
Intervention: DHA supplementation (60 mg/kg/day of DHA)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control emulsion
Number of subjects: 72
Study: 27422158

Group type: EXPERIMENTAL
Intervention: two-desk sit-to-stand workstations
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: traditional sit-to-stand workstations
Number of subjects: 18

Group type: COMPARATOR
Intervention: control group (no changes during the study)
Number of subjects: 18
Study: 24047757

Group type: EXPERIMENTAL
Intervention: 20 mg lutein/d (n=48)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: 20 mg lutein/d + 20 mg lycopene/d (n=48)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo (n=48)
Number of subjects: 144
Study: 23868654

Group type: EXPERIMENTAL
Intervention: Liposomal local therapy (LipoSaliva®, LipoNasal®, and Tears Again®) for 2 months
Number of subjects: 73
Study: 20642248

Group type: EXPERIMENTAL
Intervention: Buprenorphine transdermal system (BTDS) at 1 of 3 dose levels (5, 10, or 20 microg/b)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo transdermal system (TDS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Buprenorphine transdermal system (BTDS)
Number of subjects: 0
Study: 18828707

Group type: EXPERIMENTAL
Intervention: Selective cerebral hypothermia methods (e.g., surface cooling, intranasal selective hypothermia, transarterial or transvenous endovascular cooling, extraluminal vascular cooling, epidural cerebral cooling)
Number of subjects: 0
Study: 16627891

Group type: EXPERIMENTAL
Intervention: Glucose and 2.4 g AA/kg/d
Number of subjects: 32

Group type: COMPARATOR
Intervention: Solely glucose
Number of subjects: 32
Study: 12841468

Group type: EXPERIMENTAL
Intervention: Interviewer-administered assessment (participants' responses recorded by interviewer)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Self-answer method (participants record their own responses)
Number of subjects: 80
Study: 11015099

Group type: EXPERIMENTAL
Intervention: Multiple ITA grafts (all-ITA)
Number of subjects: 162

Group type: COMPARATOR
Intervention: ITA plus SVG (control group)
Number of subjects: 162
Study: 8843534

Group type: EXPERIMENTAL
Intervention: 0.3 mg of melatonin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 1.0 mg of melatonin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 8070301

Group type: EXPERIMENTAL
Intervention: WHO criteria for IGT
Number of subjects: 128
Study: 3311118

Group type: EXPERIMENTAL
Intervention: Histamine bronchial challenge using the DeVilbiss 646 nebulizer
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Methacholine bronchial challenge using the DeVilbiss 646 nebulizer
Number of subjects: 18
Study: 29028377

Group type: COMPARATOR
Intervention: Topical 5% minoxidil (1 ml twice daily)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Local electrodynamic microneedle treatments
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Local electrodynamic microneedle treatments plus topical 5% minoxidil (2 ml during each microneedle treatment)
Number of subjects: 60
Study: 30210790

Group type: EXPERIMENTAL
Intervention: Randomized version of the Louvain algorithm with edge and layer weights
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized version of the Louvain algorithm
Number of subjects: 0
Study: 27025868

Group type: EXPERIMENTAL
Intervention: MyKnee(®) patient-specific instrumentation (PSI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional instrumentation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MyKnee(®) PSI
Number of subjects: 0
Study: 23692645

Group type: EXPERIMENTAL
Intervention: Induced hypertension
Number of subjects: 240

Group type: COMPARATOR
Intervention: No induced hypertension
Number of subjects: 240
Study: 22876692

Group type: EXPERIMENTAL
Intervention: Bushenhuoxue Granules (BSHXG)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 20819623

Group type: EXPERIMENTAL
Intervention: Salmeterol/fluticasone (50 microg salmeterol and 500 microg fluticasone twice daily)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Ipratropium/albuterol (206 microg albuterol and 36 microg ipratropium q.i.d)
Number of subjects: 122
Study: 19128289

Group type: EXPERIMENTAL
Intervention: Home visits by mental health nurses (4 weekly visits)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Home visits by mental health nurses
Number of subjects: 18
Study: 17162329

Group type: EXPERIMENTAL
Intervention: 12.5 g soy protein
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 25 g soy protein
Number of subjects: 80

Group type: COMPARATOR
Intervention: Casein (placebo)
Number of subjects: 80
Study: 12802709

Group type: EXPERIMENTAL
Intervention: Emergent cerclage
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 23
Study: 10987850

Group type: EXPERIMENTAL
Intervention: PSP cybrid lines
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control cybrid set
Number of subjects: 0
Study: 8799385

Group type: EXPERIMENTAL
Intervention: Sitting position
Number of subjects: 32

Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Various body positions
Number of subjects: 32
Study: 1514492

Group type: EXPERIMENTAL
Intervention: Flecainide
Number of subjects: 19

Group type: COMPARATOR
Intervention: Quinidine
Number of subjects: 19
Study: 6293939

Group type: EXPERIMENTAL
Intervention: Refined carbohydrate diet
Number of subjects: 13

Group type: COMPARATOR
Intervention: Unrefined carbohydrate diet
Number of subjects: 13
Study: 31078614

Group type: EXPERIMENTAL
Intervention: Noise-synchronized animations in addition to music (n = 13)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Only music (control group, n = 15)
Number of subjects: 28
Study: 30439783

Group type: EXPERIMENTAL
Intervention: AT with participants' choice of background music
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: AT with random background music
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: AT without music
Number of subjects: 48

Group type: COMPARATOR
Intervention: No training or music control (watching videos without AT or music)
Number of subjects: 48
Study: 27302671

Group type: EXPERIMENTAL
Intervention: Decreased sugar-sweetened beverage (SSB) consumption from baseline to 9 months postpartum
Number of subjects: 65
Study: 24203262

Group type: EXPERIMENTAL
Intervention: Intravenous esmolol (0.5 mg/kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Oral propranolol (10 mg, 20 mg, 80 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Oral propranolol (80 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intravenous esmolol
Number of subjects: 12
Study: 22152114

Group type: EXPERIMENTAL
Intervention: Parenteral nutrition (PN)
Number of subjects: 47
Study: 21162458

Group type: EXPERIMENTAL
Intervention: Mid-low dose of alcohol (0.3 g/kg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Alcohol doses less than 0.5 g/kg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 17982232

Group type: COMPARATOR
Intervention: Tiotropium 18 microg once daily
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Tiotropium 18 microg once daily plus Budesonide 200 microg twice daily
Number of subjects: 100
Study: 15891595

Group type: EXPERIMENTAL
Intervention: One-point blood sampling at 12 min after Na18F injection
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Venous blood sampling at 30 min after Na18F injection
Number of subjects: 12
Study: 12204499

Group type: EXPERIMENTAL
Intervention: Ramipril (10 mg/day)
Number of subjects: 2480

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2480
Study: 9472868

Group type: EXPERIMENTAL
Intervention: Foot protection programme (index group)
Number of subjects: 2001

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2001
Study: 7657418

Group type: EXPERIMENTAL
Intervention: Albuterol (360 micrograms total, 90 micrograms per dose, 4 metered doses)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 14
Study: 2765283

Group type: EXPERIMENTAL
Intervention: Conal anaesthesia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional percutaneous anaesthesia
Number of subjects: 0
Study: 30388

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Practolol
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: H 87/07
Number of subjects: 29

Group type: COMPARATOR
Intervention: Metoprolol and Practolol
Number of subjects: 29

Group type: COMPARATOR
Intervention: All three beta-blockers
Number of subjects: 29
Study: 31375606

Group type: EXPERIMENTAL
Intervention: Levamisole 2.5 mg/kg alternate day
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 29017280

Group type: EXPERIMENTAL
Intervention: PCV13
Number of subjects: 2011

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2011
Study: 25350782

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (50,000 IU of cholecalciferol weekly for 8 weeks)
Number of subjects: 42
Study: 24066145

Group type: EXPERIMENTAL
Intervention: Patient Navigation (PN) program
Number of subjects: 1039

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1039
Study: 20538300

Group type: EXPERIMENTAL
Intervention: 30% preoperative dietary restriction (n=17)
Number of subjects: 30

Group type: COMPARATOR
Intervention: 4 d ad libitum regimen (n=13)
Number of subjects: 30